Olezarsen

DB18728ApprovedInvestigationalGene TherapiesAntisense OligonucleotidesAPOC-III-directed RNA Interaction

Olezarsen is an apolipoprotein C-III-directed antisense oligonucleotide indicated as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome or severe hypertriglyceridemia, and to reduce acute pancreatitis risk in the latter. Olezarsen is an antisense oligonucleotide directed against apolipoprotein C-III (apoC-III) mRNA, conjugated to a ligand containing three N-acetylgalactosamine (GalNAc) residues to enable delivery to hepatocytes.

Mechanism
Curator reviewed · 2 references
Primary indication
Olezarsen is indicated as an adjunct to diet: - to reduce triglycerides (TG) in adults with familial chylomicronemia syndrome (FCS). - to reduce TG and the risk of acute pancreatitis in adults with severe hypertriglyceridemia...Curator reviewed · 3 structured indications
First approval
Canada, 2026 · United States, 2024 · European Union, 2025
Also known as
ALL-P-AMBO-5'-O-(((6-(5-((TRIS(3-(6-(2-ACETAMIDO-2-DEOXY-.BETA.-D-GALACTOPYRANOSYLOXY)HEXYLAMINO)-3-OXOPROPOXYMETHYL))METHYL)AMINO-5-OXOPENTANAMIDO)HEXYL))PHOSPHO)-2'-O-(2-METHOXYETHYL)-P-THIOADENYLYL-(3'-O->5'-O)-2'-O-(2-METHOXYETHYL)-P-THIOGUANYLYL-(3 · DNA, D(P-THIO)((2'-O-(2-METHOXYETHYL))RA-(2'-O-(2-METHOXYETHYL))RG-(2'-O-(2-METHOXYETHYL))M5RC-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-M5C-T-T-G-T-M5C-M5C-A-G-M5C-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETHYL))M5RU-(2'-O-(2-METHOXYETH · IONIS-APOCIII-LRX · ISIS-APOCIII-LRX
Code names
AKCEA-APOCIII-LRx · ISIS-678354
Brand names
  • Tryngolza

Resolves to

Clinical / RWD

What you can answer from here — as of November 02, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
4Marketed productsAcross 3 countries and 3 labellers
Sign in
10+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Olezarsen, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account